Protein biomarkers of disease progression in patients with systemic sclerosis associated interstitia...
Protein biomarkers of disease progression in patients with systemic sclerosis associated interstitial lung disease
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Systemic sclerosis is a rare connective tissue disease; and interstitial lung disease (SSc–ILD) is associated with significant morbidity and mortality. There are no clinical, radiologic features, nor biomarkers that identify the specific time when patients are at risk for progression at which the benefits from treatment outweigh the risks. Our stud...
Alternative Titles
Full title
Protein biomarkers of disease progression in patients with systemic sclerosis associated interstitial lung disease
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_8d2b4e565b614956a6c5be07b6e6a75a
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8d2b4e565b614956a6c5be07b6e6a75a
Other Identifiers
ISSN
2045-2322
E-ISSN
2045-2322
DOI
10.1038/s41598-023-35840-y
